Fulgent Genetics, Inc.
US ˙ NasdaqGM ˙ US3596641098

SecurityFLGT / Fulgent Genetics, Inc.
InstitutionShell Asset Management Co
Latest Disclosed Ownership3,171 shares
Latest Disclosed Value $ 72
Shell Asset Management Co reports 56.48% decrease in ownership of FLGT / Fulgent Genetics, Inc.

On November 7, 2025 - Shell Asset Management Co filed a 13F-HR form disclosing ownership of 3,171 shares of Fulgent Genetics, Inc. (US:FLGT) valued at $71,665 USD as of September 30, 2025. The entity filed a previous 13F-HR on July 23, 2025 disclosing 7,286 shares of Fulgent Genetics, Inc.. The current value of the position is $61,834 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2025-11-07 2025-09-30 13F FULGENT GENETICS COM 359664109 3,171 -4,115 -56.48 0 0.0072
2025-07-23 2025-06-30 13F FULGENT GENETICS COM 359664109 7,286 -1,804 -19.85 0 0.0050
2025-05-14 2025-03-31 13F FULGENT GENETICS COM 359664109 9,090 -384 -4.05 0 0.0073
2025-02-14 2024-12-31 13F FULGENT GENETICS COM 359664109 9,474 0 0.00 0 0.0076
2024-11-07 2024-09-30 13F FULGENT GENETICS COM 359664109 9,474 -335 -3.42 0 0.0091
2024-07-25 2024-03-31 13F FULGENT GENETICS COM 359664109 9,809 -988 -9.15 0 0.0087
2024-02-14 2023-12-31 13F FULGENT GENETICS COM 359664109 10,797 -3,235 -23.05 0 0.0144
2023-11-08 2023-09-30 13F FULGENT GENETICS COM 359664109 14,032 -244 -1.71 0 0.0155
2023-07-28 2023-06-30 13F FULGENT GENETICS COM 359664109 14,276 -2,290 -13.82 1 0.0209
2023-05-15 2023-03-31 13F FULGENT GENETICS COM 359664109 16,566 12,815 341.64 1 0.0215
2023-02-07 2022-12-31 13F FULGENT GENETICS COM 359664109 3,751 -763 -16.90 0 -100.00 0.0049
2022-11-14 2022-09-30 13F FULGENT GENETICS COM 359664109 4,514 954 26.80 172 -11.34 0.0067
2022-08-09 2022-06-30 13F FULGENT GENETICS COM 359664109 3,560 1,143 47.29 194 28.48 0.0057
2022-05-04 2022-03-31 13F FULGENT GENETICS COM 359664109 2,417 -357 -12.87 151 -45.88 0.0036
2022-02-09 2021-12-31 13F FULGENT GENETICS COM 359664109 2,774 13 0.47 279 12.50 0.0057
2021-11-04 2021-09-30 13F FULGENT GENETICS COM 359664109 2,761 -120 -4.17 248 -6.77 0.0056
2021-08-12 2021-06-30 13F FULGENT GENETICS COM 359664109 2,881 2,881 266 0.0052
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.